Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Dec;85(12):1900–1913. doi: 10.1054/bjoc.2001.2164

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma

T Stokke 1, P DeAngelis 2, L Smedshammer 1, E Galteland 1, H B Steen 1, E B Smeland 3, J Delabie 4, H Holte 5
PMCID: PMC2364025  PMID: 11747333

Abstract

Comparative genomic hybridization (CGH) was employed to study chromosomal aberrations in relation to cell proliferation, apoptosis, and patient survival in 94 cases of B-cell non-Hodgkin's lymphoma diagnosed between 1983 and 1993. Eighty cases had aberrations by CGH. Chromosomal regions 1p21–31.1 (10%), 6cen-q24 (12%), 8p (11%), 9p21-ter (14%), 11q21–23.1 (11%), 13q13–21.1 (12%), and 17p (15%) were frequently lost. Gains were found at 3q21-ter (22%), 6p (11%), 7p (12%), 8q23-ter (13%), 12cen-q15 (17%), 17q24-ter (13%), and 18q13.3–21 (20%). A high number of aberrations (≥ 4, 33 cases) was associated (P ≤ 0.001) with the mantle cell and diffuse large B-cell lymphoma subtypes, a high fraction of tumour cells in S phase, and short survival (RR (relative risk) = 3.7). Loss of 1p21–31.1, 8p, 9p21-ter, 11q21–23.1, and 13q13–21.1 were associated with mantle cell lymphoma (P ≤ 0.03), while gain of 6p and 12cen-q15 were more frequent in diffuse large B-cell and small lymphocytic lymphoma, respectively (P = 0.04). Loss of 8p and 17p, and gain of 3q21-ter, 6p, 7p, and 8q23-ter were associated with a high S phase fraction (P ≤ 0.03), but none of the aberrations were associated with tumour apoptotic fraction (P ≥ 0.13). The most important prognostic CGH parameters (P < 0.001) were losses of 11q21–23.1 (RR = 3.8) and 17p (RR = 4.4), and gain of 6p (RR = 4.2). The latter parameters and IPI were the only ones with independent prognostic value (RR = 10, 5.0, 6.7, and 3.7, respectively; P < 0.001) when assessed together with lymphoma sub-type, primary versus relapse cases, treatment, B symptoms, S phase fraction, and presence of BCL1 and BCL2 translocations. A combined CGH/IPI binary parameter had high prognostic value for patients receiving different treatments, with various lymphoma sub-types, and for primary as well as relapse cases.© 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: non-Hodgkin's lymphoma; chromosomal aberrations, survival

Full Text

The Full Text of this article is available as a PDF (213.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Autio K., Aalto Y., Franssila K., Elonen E., Joensuu H., Knuutila S. Low number of DNA copy number changes in small lymphocytic lymphoma. Haematologica. 1998 Aug;83(8):690–692. [PubMed] [Google Scholar]
  2. Bentz M., Huck K., du Manoir S., Joos S., Werner C. A., Fischer K., Döhner H., Lichter P. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood. 1995 Jun 15;85(12):3610–3618. [PubMed] [Google Scholar]
  3. Bentz M., Plesch A., Bullinger L., Stilgenbauer S., Ott G., Müller-Hermelink H. K., Baudis M., Barth T. F., Möller P., Lichter P. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2000 Mar;27(3):285–294. [PubMed] [Google Scholar]
  4. Bentz M., Werner C. A., Döhner H., Joos S., Barth T. F., Siebert R., Schröder M., Stilgenbauer S., Fischer K., Möller P. High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood. 1996 Aug 15;88(4):1437–1444. [PubMed] [Google Scholar]
  5. Beà S., Ribas M., Hernández J. M., Bosch F., Pinyol M., Hernández L., García J. L., Flores T., González M., López-Guillermo A. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999 Jun 15;93(12):4365–4374. [PubMed] [Google Scholar]
  6. Bullrich F., Rasio D., Kitada S., Starostik P., Kipps T., Keating M., Albitar M., Reed J. C., Croce C. M. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res. 1999 Jan 1;59(1):24–27. [PubMed] [Google Scholar]
  7. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  8. Dierlamm J., Rosenberg C., Stul M., Pittaluga S., Wlodarska I., Michaux L., Dehaen M., Verhoef G., Thomas J., de Kelver W. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization. Leukemia. 1997 May;11(5):747–758. doi: 10.1038/sj.leu.2400635. [DOI] [PubMed] [Google Scholar]
  9. Döhner H., Fischer K., Bentz M., Hansen K., Benner A., Cabot G., Diehl D., Schlenk R., Coy J., Stilgenbauer S. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood. 1995 Mar 15;85(6):1580–1589. [PubMed] [Google Scholar]
  10. Döhner H., Stilgenbauer S., Benner A., Leupolt E., Kröber A., Bullinger L., Döhner K., Bentz M., Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000 Dec 28;343(26):1910–1916. doi: 10.1056/NEJM200012283432602. [DOI] [PubMed] [Google Scholar]
  11. Döhner H., Stilgenbauer S., James M. R., Benner A., Weilguni T., Bentz M., Fischer K., Hunstein W., Lichter P. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood. 1997 Apr 1;89(7):2516–2522. [PubMed] [Google Scholar]
  12. Fisher R. I., Gaynor E. R., Dahlberg S., Oken M. M., Grogan T. M., Mize E. M., Glick J. H., Coltman C. A., Jr, Miller T. P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993 Apr 8;328(14):1002–1006. doi: 10.1056/NEJM199304083281404. [DOI] [PubMed] [Google Scholar]
  13. Galteland E., Holte H., Stokke T. c-MYC, RB-1, TP53, and centromere 8 and 17 copy number in B-cell non-Hodgkin's lymphomas assessed by dual-color fluorescence in situ hybridization. Cytometry. 1999 Apr 15;38(2):53–60. doi: 10.1002/(sici)1097-0320(19990415)38:2<53::aid-cyto2>3.3.co;2-s. [DOI] [PubMed] [Google Scholar]
  14. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994 Sep 1;84(5):1361–1392. [PubMed] [Google Scholar]
  15. Hernandez L., Fest T., Cazorla M., Teruya-Feldstein J., Bosch F., Peinado M. A., Piris M. A., Montserrat E., Cardesa A., Jaffe E. S. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood. 1996 Apr 15;87(8):3351–3359. [PubMed] [Google Scholar]
  16. Kallioniemi A., Kallioniemi O. P., Piper J., Tanner M., Stokke T., Chen L., Smith H. S., Pinkel D., Gray J. W., Waldman F. M. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2156–2160. doi: 10.1073/pnas.91.6.2156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kallioniemi O. P., Kallioniemi A., Piper J., Isola J., Waldman F. M., Gray J. W., Pinkel D. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer. 1994 Aug;10(4):231–243. doi: 10.1002/gcc.2870100403. [DOI] [PubMed] [Google Scholar]
  18. Knutsen T. Cytogenetic changes in the progression of lymphoma. Leuk Lymphoma. 1998 Sep;31(1-2):1–19. doi: 10.3109/10428199809057581. [DOI] [PubMed] [Google Scholar]
  19. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 1997 Feb 7;88(3):323–331. doi: 10.1016/s0092-8674(00)81871-1. [DOI] [PubMed] [Google Scholar]
  20. Mitelman F., Mertens F., Johansson B. A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet. 1997 Apr;15(Spec No):417–474. doi: 10.1038/ng0497supp-417. [DOI] [PubMed] [Google Scholar]
  21. Monni O., Joensuu H., Franssila K., Klefstrom J., Alitalo K., Knuutila S. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. Blood. 1997 Aug 1;90(3):1168–1174. [PubMed] [Google Scholar]
  22. Monni O., Joensuu H., Franssila K., Knuutila S. DNA copy number changes in diffuse large B-cell lymphoma--comparative genomic hybridization study. Blood. 1996 Jun 15;87(12):5269–5278. [PubMed] [Google Scholar]
  23. Monni O., Oinonen R., Elonen E., Franssila K., Teerenhovi L., Joensuu H., Knuutila S. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer. 1998 Apr;21(4):298–307. doi: 10.1002/(sici)1098-2264(199804)21:4<298::aid-gcc3>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  24. Offit K. Chromosome analysis in the management of patients with non-Hodgkin's lymphoma. Leuk Lymphoma. 1992 Jul;7(4):275–282. doi: 10.3109/10428199209049778. [DOI] [PubMed] [Google Scholar]
  25. Ong S. T., Le Beau M. M. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma. Semin Oncol. 1998 Aug;25(4):447–460. [PubMed] [Google Scholar]
  26. Panayiotidis P., Kotsi P. Genetics of small lymphocyte disorders. Semin Hematol. 1999 Apr;36(2):171–177. [PubMed] [Google Scholar]
  27. Pui C. H., Evans W. E. Acute lymphoblastic leukemia. N Engl J Med. 1998 Aug 27;339(9):605–615. doi: 10.1056/NEJM199808273390907. [DOI] [PubMed] [Google Scholar]
  28. Rabbitts T. H. Chromosomal translocations in human cancer. Nature. 1994 Nov 10;372(6502):143–149. doi: 10.1038/372143a0. [DOI] [PubMed] [Google Scholar]
  29. Sander C. A., Yano T., Clark H. M., Harris C., Longo D. L., Jaffe E. S., Raffeld M. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993 Oct 1;82(7):1994–2004. [PubMed] [Google Scholar]
  30. Schaffner C., Idler I., Stilgenbauer S., Döhner H., Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2773–2778. doi: 10.1073/pnas.050400997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Schoch C., Rieder H., Stollmann-Gibbels B., Freund M., Tischler H. J., Silling-Engelhardt G., Fonatsch C. 17p anomalies in lymphoid malignancies: diagnostic and prognostic implications. Leuk Lymphoma. 1995 Apr;17(3-4):271–279. doi: 10.3109/10428199509056832. [DOI] [PubMed] [Google Scholar]
  32. Schouten H. C., Sanger W. G., Weisenburger D. D., Anderson J., Armitage J. O. Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. Blood. 1990 May 1;75(9):1841–1847. [PubMed] [Google Scholar]
  33. Sherr C. J. Cancer cell cycles. Science. 1996 Dec 6;274(5293):1672–1677. doi: 10.1126/science.274.5293.1672. [DOI] [PubMed] [Google Scholar]
  34. Stokke T., Galteland E., Holte H., Smedshammer L., Suo Z., Smeland E. B., Børresen-Dale A. L., DeAngelis P., Steen H. B. Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in B-cell Non-Hodgkin's lymphoma. Int J Cancer. 2000 Jul 20;89(4):313–324. doi: 10.1002/1097-0215(20000720)89:4<313::aid-ijc1>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  35. Stokke T., Holte H., Smedshammer L., Smeland E. B., Kaalhus O., Steen H. B. Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas. Br J Cancer. 1998 Jun;77(11):1832–1838. doi: 10.1038/bjc.1998.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stokke T., Smeland E. B., Kvaløy S., Holte H. Tumour cell proliferation, but not apoptosis, predicts survival in B-cell non-Hodgkin's lymphomas. Br J Cancer. 1998 Jun;77(11):1839–1841. doi: 10.1038/bjc.1998.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tilly H., Rossi A., Stamatoullas A., Lenormand B., Bigorgne C., Kunlin A., Monconduit M., Bastard C. Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood. 1994 Aug 15;84(4):1043–1049. [PubMed] [Google Scholar]
  38. Tirkkonen M., Tanner M., Karhu R., Kallioniemi A., Isola J., Kallioniemi O. P. Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer. 1998 Mar;21(3):177–184. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES